Another neurodegenerative disease, in which, however, the role of REST had been considered only marginal, is Parkinson’s disease that in Europe affects 1.2 million patients, corresponding to 7.5% of the REST-dependent population (Figure 2A). Here, REST is linked to neurodegenerative disease.